Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Binds to the promoters of target genes and functions as repressor. Additionally we are shipping and many more products for this protein.
Showing 10 out of 72 products:
Human Polyclonal ZNF217 Primary Antibody for EIA, WB - ABIN955690
Krig, Miller, Frietze, Beckett, Neve, Farnham, Yaswen, Sweeney: ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells. in Oncogene 2010
Show all 5 references for ABIN955690
Chicken Polyclonal ZNF217 Primary Antibody for WB - ABIN2778003
Sun, Zhou, Yin, Ding, Zhong: Silencing of ZNF217 gene influences the biological behavior of a human ovarian cancer cell line. in International journal of oncology 2008
Human Polyclonal ZNF217 Primary Antibody for IHC, ELISA - ABIN185663
Huang, Krig, Kowbel, Xu, Hyun, Volik, Feuerstein, Mills, Stokoe, Yaswen, Collins: ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction. in Human molecular genetics 2005
High expression of ZNF217 is associated with enhanced cell migration and invasion in colorectal carcinoma.
Two polymorphisms in ZNF217 in Mexican patients with colorectal cancer, were studied.
ZNF217 has an oncogenic role in colorectal cancer and is regulated by miR (show MLXIP Antibodies)-203.
we conclude that ZNF217 may contribute to ovarian cancer invasion and metastasis, and associated with worse clinical outcomes.
Synergic effects of loss of ARID1A (show ARID1A Antibodies) and PI3K (show PIK3CA Antibodies)-Akt (show AKT1 Antibodies) pathway activation as well as ZNF217 amplification may be related to the development of ovarian clear cell carcinoma.
ERalpha (show ESR1 Antibodies) expression highly correlates with ZNF217 in lysates from breast tumors.
ZNF217 expression seems to be a novel prognostic biomarker in gastric cancer.
Study investigated nested regulatory circuits of miR (show MLXIP Antibodies)-200c/ZEB1 (show ZEB1 Antibodies) and miR (show MLXIP Antibodies)-200c/ZNF217/TGF-beta (show TGFB1 Antibodies)/ZEB1 (show ZEB1 Antibodies) in synergistically promoting trastuzumab resistance and metastasis of breast cancer cells.
New insights into DNA recognition by zinc fingers revealed by structural analysis of the oncoprotein ZNF217.
downregulation of miR (show MLXIP Antibodies)-24ZNF17 in prostate cancer (PCa (show FLVCR1 Antibodies)) corresponds to an upregulation of ZNF217; ZNF217 could be identified as an oncogene (show RAB1A Antibodies) because it is overexpressed in prostate cancer (PCa (show FLVCR1 Antibodies)) and affects the growth of PCa (show FLVCR1 Antibodies) cell lines
results show that ZNF217 regulates ErbB3 (show ERBB3 Antibodies) expression
These results identify a new CtBP (show CTBP2 Antibodies) interaction motif and establish ZNF217 as a transcriptional repressor protein that functions, at least in part, by associating with CtBP (show CTBP2 Antibodies).
Binds to the promoters of target genes and functions as repressor. Promotes cell proliferation and antagonizes cell death. Promotes phosphorylation of AKT1 at 'Ser-473'.
zinc finger protein 217
, novel zinc finger protein